1. Home
  2. TYGO vs HELP Comparison

TYGO vs HELP Comparison

Compare TYGO & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tigo Energy Inc.

TYGO

Tigo Energy Inc.

HOLD

Current Price

$4.80

Market Cap

380.1M

Sector

Technology

ML Signal

HOLD

HELP

Cybin Inc. Common Stock

N/A

Current Price

$5.17

Market Cap

279.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TYGO
HELP
Founded
2007
N/A
Country
United States
Canada
Employees
N/A
50
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
380.1M
279.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TYGO
HELP
Price
$4.80
$5.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$6.00
$51.50
AVG Volume (30 Days)
537.1K
1.5M
Earning Date
05-05-2026
07-01-2026
Dividend Yield
N/A
N/A
EPS Growth
97.12
N/A
EPS
N/A
N/A
Revenue
$103,536,000.00
N/A
Revenue This Year
$30.78
N/A
Revenue Next Year
$21.68
N/A
P/E Ratio
N/A
N/A
Revenue Growth
91.68
N/A
52 Week Low
$0.81
$4.29
52 Week High
$5.33
$8.55

Technical Indicators

Market Signals
Indicator
TYGO
HELP
Relative Strength Index (RSI) 59.79 46.93
Support Level $3.24 $4.55
Resistance Level N/A $8.55
Average True Range (ATR) 0.46 0.46
MACD 0.05 -0.01
Stochastic Oscillator 68.85 22.72

Price Performance

Historical Comparison
TYGO
HELP

About TYGO Tigo Energy Inc.

Tigo Energy Inc provides solar and energy storage solutions, including module level power electronics (MLPE) designed to maximize the energy output of individual solar modules, delivering more energy, active management, and enhanced safety for utility, commercial, and residential solar arrays. By combining its MLPE and solar optimizer technology with intelligent, cloud-based software capabilities, the Company enables developed energy monitoring, system diagnostics, and real-time control. Geographically the company generates revenue from EMEA, Americas, and APAC.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: